Review




Structured Review

Abnova mouse monoclonal anti-cb2 antibody
Patients’ characteristics categorized by gender, clinical stage, grading, and histology
Mouse Monoclonal Anti Cb2 Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/mouse+monoclonal+anti+cb2+antibody/pmc09641041-96-13-17
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-cb2 antibody - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival"

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

Journal: Translational Lung Cancer Research

doi: 10.21037/tlcr-22-247

Patients’ characteristics categorized by gender, clinical stage, grading, and histology
Figure Legend Snippet: Patients’ characteristics categorized by gender, clinical stage, grading, and histology

Techniques Used: Paraffin-embedded Immunohistochemistry

Kaplan-Meier analysis of OS, CSS, and DFS for CB2 gene (A) and protein (B) expression positivity in tumor tissue. CB2, cannabinoid receptor 2; qRT-PCR, quantitative reverse-transcriptase polymerase chain reaction; neg., negative; pos., positive; HR, hazard ratio; IHC, immunohistochemistry; OS, overall survival; CSS, cancer specific survival; DFS, disease free survival.
Figure Legend Snippet: Kaplan-Meier analysis of OS, CSS, and DFS for CB2 gene (A) and protein (B) expression positivity in tumor tissue. CB2, cannabinoid receptor 2; qRT-PCR, quantitative reverse-transcriptase polymerase chain reaction; neg., negative; pos., positive; HR, hazard ratio; IHC, immunohistochemistry; OS, overall survival; CSS, cancer specific survival; DFS, disease free survival.

Techniques Used: Expressing, Quantitative RT-PCR, Reverse Transcription, Polymerase Chain Reaction, Immunohistochemistry

Patients’ characteristics categorized by weight and BMI
Figure Legend Snippet: Patients’ characteristics categorized by weight and BMI

Techniques Used: Paraffin-embedded Immunohistochemistry

CB1 (A) and CB2 (B) gene expression (ΔCT values) in tumor and tumor-free lung tissue from 10 NSCLC patients. NSCLC, non-small cell lung cancer; CB1, cannabinoid receptor 1; CT, cycle threshold; CB2, cannabinoid receptor 2.
Figure Legend Snippet: CB1 (A) and CB2 (B) gene expression (ΔCT values) in tumor and tumor-free lung tissue from 10 NSCLC patients. NSCLC, non-small cell lung cancer; CB1, cannabinoid receptor 1; CT, cycle threshold; CB2, cannabinoid receptor 2.

Techniques Used: Expressing

Immunohistochemical staining of FFPE tumor tissue samples of NSCLC patients using anti-CB1 and anti-CB2 monoclonal antibodies (under ×10 lens). IHC, immunohistochemistry; CB1, cannabinoid receptor 1; CB2, cannabinoid receptor 2; FFPE, formalin-fixed paraffin-embedded; NSCLC, non-small cell lung cancer.
Figure Legend Snippet: Immunohistochemical staining of FFPE tumor tissue samples of NSCLC patients using anti-CB1 and anti-CB2 monoclonal antibodies (under ×10 lens). IHC, immunohistochemistry; CB1, cannabinoid receptor 1; CB2, cannabinoid receptor 2; FFPE, formalin-fixed paraffin-embedded; NSCLC, non-small cell lung cancer.

Techniques Used: Immunohistochemical staining, Staining, Immunohistochemistry, Formalin-fixed Paraffin-Embedded

Related Articles

Staining:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Paraffin-embedded Immunohistochemistry:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Expressing:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Quantitative RT-PCR:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Reverse Transcription:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Polymerase Chain Reaction:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Immunohistochemistry:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Immunohistochemical staining:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Formalin-fixed Paraffin-Embedded:

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.



Similar Products

93
Santa Cruz Biotechnology cb2 3c7 mouse monoclonal igg
Primary and secondary antisera used for Western blot, IFL, and IHC.
Cb2 3c7 Mouse Monoclonal Igg, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/CB2+Antibody/pmc10602894-2-0-6
Average 93 stars, based on 1 article reviews
cb2 3c7 mouse monoclonal igg - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
R&D Systems mouse monoclonal anti-cb2 antibody
Primary and secondary antisera used for Western blot, IFL, and IHC.
Mouse Monoclonal Anti Cb2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/mouse+monoclonal+anti+cb2+antibody/us11566069-1100-0-5
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-cb2 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Abnova mouse monoclonal anti-cb2 antibody
Patients’ characteristics categorized by gender, clinical stage, grading, and histology
Mouse Monoclonal Anti Cb2 Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/mouse+monoclonal+anti+cb2+antibody/pmc09641041-96-13-17
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-cb2 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal anti cb2 antibody
Figure 8. Modulation of <t>CB2</t> receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOJ (organic extract from Felina 32 hemp inflorescences collected in June), the corresponding mFOJ cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOJ extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOJ; 3. mFOJ; 4. Cannabidiol, 0.8 µg/mL; 5. Cannabichromene, 0.04 µg/mL; 6. α-Humulene, 0.01 µg/mL; 7. β-Caryophyllene, 0.01 µg/mL; 8. β-Caryophyllene oxide, 0.007 µg/mL.
Mouse Monoclonal Anti Cb2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/CB2+Antibody/pm34771097-273-33-38
Average 93 stars, based on 1 article reviews
mouse monoclonal anti cb2 antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal anti cb 2 r antibody
Figure 8. Modulation of <t>CB2</t> receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOJ (organic extract from Felina 32 hemp inflorescences collected in June), the corresponding mFOJ cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOJ extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOJ; 3. mFOJ; 4. Cannabidiol, 0.8 µg/mL; 5. Cannabichromene, 0.04 µg/mL; 6. α-Humulene, 0.01 µg/mL; 7. β-Caryophyllene, 0.01 µg/mL; 8. β-Caryophyllene oxide, 0.007 µg/mL.
Mouse Monoclonal Anti Cb 2 R Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/CB2+Antibody/pmc08576920-314-39-47
Average 93 stars, based on 1 article reviews
mouse monoclonal anti cb 2 r antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology anti-cb2r mouse monoclonal antibody cb2(3c7):sc293188
Figure 8. Modulation of <t>CB2</t> receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOJ (organic extract from Felina 32 hemp inflorescences collected in June), the corresponding mFOJ cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOJ extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOJ; 3. mFOJ; 4. Cannabidiol, 0.8 µg/mL; 5. Cannabichromene, 0.04 µg/mL; 6. α-Humulene, 0.01 µg/mL; 7. β-Caryophyllene, 0.01 µg/mL; 8. β-Caryophyllene oxide, 0.007 µg/mL.
Anti Cb2r Mouse Monoclonal Antibody Cb2(3c7):Sc293188, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/anti+cb2/pm31954990-502-10-17
Average 90 stars, based on 1 article reviews
anti-cb2r mouse monoclonal antibody cb2(3c7):sc293188 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
R&D Systems mouse monoclonal antibody against human cannabinoid receptor cb 2
Figure 8. Modulation of <t>CB2</t> receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOJ (organic extract from Felina 32 hemp inflorescences collected in June), the corresponding mFOJ cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOJ extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOJ; 3. mFOJ; 4. Cannabidiol, 0.8 µg/mL; 5. Cannabichromene, 0.04 µg/mL; 6. α-Humulene, 0.01 µg/mL; 7. β-Caryophyllene, 0.01 µg/mL; 8. β-Caryophyllene oxide, 0.007 µg/mL.
Mouse Monoclonal Antibody Against Human Cannabinoid Receptor Cb 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti-cb2+antibody/Human+Cannabinoid+R2%2FCB2%2FCNR2+Antibody/pmc07546613-297-11-20
Average 94 stars, based on 1 article reviews
mouse monoclonal antibody against human cannabinoid receptor cb 2 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Primary and secondary antisera used for Western blot, IFL, and IHC.

Journal: Frontiers in Endocrinology

Article Title: The interplay between kisspeptin and endocannabinoid systems modulates male hypothalamic and gonadic control of reproduction in vivo

doi: 10.3389/fendo.2023.1269334

Figure Lengend Snippet: Primary and secondary antisera used for Western blot, IFL, and IHC.

Article Snippet: CB2 (3C7) mouse monoclonal IgG (sc-293188, Santa Cruz Biotechnology) , 1:3000.

Techniques: Western Blot, Plasmid Preparation

Distribution of CB1 and CB2 in rat testis treated with KP and AEA. Double immunofluorescence of CB1 (green) and CB2 (red) expression in control (C), kisspeptin (KP), anandamide (AEA), and SR141716A plus AEA (SR + AEA)-treated animals ( n = 4 for each group). Magnification = C and KP ×63; AEA and SR + AEA, ×40. * Elongated spermatids, ↑ spermatocytes, ^ spermatogonia, Δ Sertoli cells, ° interstitium.

Journal: Frontiers in Endocrinology

Article Title: The interplay between kisspeptin and endocannabinoid systems modulates male hypothalamic and gonadic control of reproduction in vivo

doi: 10.3389/fendo.2023.1269334

Figure Lengend Snippet: Distribution of CB1 and CB2 in rat testis treated with KP and AEA. Double immunofluorescence of CB1 (green) and CB2 (red) expression in control (C), kisspeptin (KP), anandamide (AEA), and SR141716A plus AEA (SR + AEA)-treated animals ( n = 4 for each group). Magnification = C and KP ×63; AEA and SR + AEA, ×40. * Elongated spermatids, ↑ spermatocytes, ^ spermatogonia, Δ Sertoli cells, ° interstitium.

Article Snippet: CB2 (3C7) mouse monoclonal IgG (sc-293188, Santa Cruz Biotechnology) , 1:3000.

Techniques: Immunofluorescence, Expressing, Control

Patients’ characteristics categorized by gender, clinical stage, grading, and histology

Journal: Translational Lung Cancer Research

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

doi: 10.21037/tlcr-22-247

Figure Lengend Snippet: Patients’ characteristics categorized by gender, clinical stage, grading, and histology

Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Techniques: Paraffin-embedded Immunohistochemistry

Kaplan-Meier analysis of OS, CSS, and DFS for CB2 gene (A) and protein (B) expression positivity in tumor tissue. CB2, cannabinoid receptor 2; qRT-PCR, quantitative reverse-transcriptase polymerase chain reaction; neg., negative; pos., positive; HR, hazard ratio; IHC, immunohistochemistry; OS, overall survival; CSS, cancer specific survival; DFS, disease free survival.

Journal: Translational Lung Cancer Research

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

doi: 10.21037/tlcr-22-247

Figure Lengend Snippet: Kaplan-Meier analysis of OS, CSS, and DFS for CB2 gene (A) and protein (B) expression positivity in tumor tissue. CB2, cannabinoid receptor 2; qRT-PCR, quantitative reverse-transcriptase polymerase chain reaction; neg., negative; pos., positive; HR, hazard ratio; IHC, immunohistochemistry; OS, overall survival; CSS, cancer specific survival; DFS, disease free survival.

Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Techniques: Expressing, Quantitative RT-PCR, Reverse Transcription, Polymerase Chain Reaction, Immunohistochemistry

Patients’ characteristics categorized by weight and BMI

Journal: Translational Lung Cancer Research

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

doi: 10.21037/tlcr-22-247

Figure Lengend Snippet: Patients’ characteristics categorized by weight and BMI

Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Techniques: Paraffin-embedded Immunohistochemistry

CB1 (A) and CB2 (B) gene expression (ΔCT values) in tumor and tumor-free lung tissue from 10 NSCLC patients. NSCLC, non-small cell lung cancer; CB1, cannabinoid receptor 1; CT, cycle threshold; CB2, cannabinoid receptor 2.

Journal: Translational Lung Cancer Research

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

doi: 10.21037/tlcr-22-247

Figure Lengend Snippet: CB1 (A) and CB2 (B) gene expression (ΔCT values) in tumor and tumor-free lung tissue from 10 NSCLC patients. NSCLC, non-small cell lung cancer; CB1, cannabinoid receptor 1; CT, cycle threshold; CB2, cannabinoid receptor 2.

Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Techniques: Expressing

Immunohistochemical staining of FFPE tumor tissue samples of NSCLC patients using anti-CB1 and anti-CB2 monoclonal antibodies (under ×10 lens). IHC, immunohistochemistry; CB1, cannabinoid receptor 1; CB2, cannabinoid receptor 2; FFPE, formalin-fixed paraffin-embedded; NSCLC, non-small cell lung cancer.

Journal: Translational Lung Cancer Research

Article Title: Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

doi: 10.21037/tlcr-22-247

Figure Lengend Snippet: Immunohistochemical staining of FFPE tumor tissue samples of NSCLC patients using anti-CB1 and anti-CB2 monoclonal antibodies (under ×10 lens). IHC, immunohistochemistry; CB1, cannabinoid receptor 1; CB2, cannabinoid receptor 2; FFPE, formalin-fixed paraffin-embedded; NSCLC, non-small cell lung cancer.

Article Snippet: Samples were stained using mouse monoclonal anti-CB1 antibody (ImmunoGenes, Cat# 01, RRID:AB_2910137) and mouse monoclonal anti-CB2 antibody (Abnova, Cat# H00001269-M01, RRID:AB_875479) according to the manufacturer’s protocol.

Techniques: Immunohistochemical staining, Staining, Immunohistochemistry, Formalin-fixed Paraffin-Embedded

Figure 8. Modulation of CB2 receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOJ (organic extract from Felina 32 hemp inflorescences collected in June), the corresponding mFOJ cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOJ extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOJ; 3. mFOJ; 4. Cannabidiol, 0.8 µg/mL; 5. Cannabichromene, 0.04 µg/mL; 6. α-Humulene, 0.01 µg/mL; 7. β-Caryophyllene, 0.01 µg/mL; 8. β-Caryophyllene oxide, 0.007 µg/mL.

Journal: Molecules (Basel, Switzerland)

Article Title: Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells.

doi: 10.3390/molecules26216688

Figure Lengend Snippet: Figure 8. Modulation of CB2 receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOJ (organic extract from Felina 32 hemp inflorescences collected in June), the corresponding mFOJ cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOJ extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOJ; 3. mFOJ; 4. Cannabidiol, 0.8 µg/mL; 5. Cannabichromene, 0.04 µg/mL; 6. α-Humulene, 0.01 µg/mL; 7. β-Caryophyllene, 0.01 µg/mL; 8. β-Caryophyllene oxide, 0.007 µg/mL.

Article Snippet: After blocking with 3% bovine serum albumin (BSA) in PBS for 30 min at room temperature, cells were incubated for 1 h, at room temperature, with Molecules 2021, 26, 6688 18 of 20 mouse monoclonal anti-CB2 antibody 1:150 (Santa Cruz Biotechnology, Inc., Dallas, TE, USA).

Techniques: Expressing, Software, Control, Comparison

Figure 9. Modulation of CB2 receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOS (organic extract from Felina 32 hemp inflorescences collected in September), the corresponding mFOS cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOS extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOS; 3. mFOS; 4. Cannabidiol, 3.4 µg/mL; 5. Cannabichromene, 1.2 µg/mL; 6. α-Humulene, 0.02 µg/mL; 7. β-Caryophyllene, 0.02 µg/mL; 8. β-Caryophyllene oxide, 0.02 µg/mL.

Journal: Molecules (Basel, Switzerland)

Article Title: Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells.

doi: 10.3390/molecules26216688

Figure Lengend Snippet: Figure 9. Modulation of CB2 receptor expression in MDA-MB-468 cells detected after 24 h treatment with 10 µg/mL FOS (organic extract from Felina 32 hemp inflorescences collected in September), the corresponding mFOS cocktail, and with the nonintoxicating phytocannabinoids and caryophyllane sesquiterpenes contained in FOS extract. (A) Representative images obtained at immunofluorescence analysis. (B) Densitometric analysis of immunofluorescence carried out by the free software ImageJ (n = 6). ** p < 0.01 and *** p < 0.001, significant difference respect to the control (ANOVA + Dunnett’s Multiple Comparison PostTest). 1. Control; 2. FOS; 3. mFOS; 4. Cannabidiol, 3.4 µg/mL; 5. Cannabichromene, 1.2 µg/mL; 6. α-Humulene, 0.02 µg/mL; 7. β-Caryophyllene, 0.02 µg/mL; 8. β-Caryophyllene oxide, 0.02 µg/mL.

Article Snippet: After blocking with 3% bovine serum albumin (BSA) in PBS for 30 min at room temperature, cells were incubated for 1 h, at room temperature, with Molecules 2021, 26, 6688 18 of 20 mouse monoclonal anti-CB2 antibody 1:150 (Santa Cruz Biotechnology, Inc., Dallas, TE, USA).

Techniques: Expressing, Software, Control, Comparison